Virginia Pharmacists Association

Update on Labeling for Azilect (rasagiline tablets):

R. Steven Meadows, MD

Hampton Roads / Riverside Neurology

Marriott Newport News at City Center

740 Town Center Dr

Newport News, Va. 23606

Sunday March 21, 2010

6:30 pm Reception

7:00 pm Dinner & Presentation

RSVP

Patrick McKeever Teva Neuroscience Inc.

1-866-227-9788 ext. 5781

(Pat Resto, President Peninsula Pharmacists Association)

An MOA-B Selective Inhibitor Indicated for Use as Mono or Adjunct Therapy in Parkinson’s Disease

PENINSULA PHARMACISTS ASSOCIATION and

Presents:

Strategies to Reduce the Risk of Diabetes Complications

Date:
Thursday, December 3, 2009
Time:

6:00 PM - 9:00 PM
Location:

5363 Richmond Road

Williamsburg, VA 23188

Captain George's Seafood Restaurant
To Register,
Click the link below:
http://server2.mycecenter.com/CeRegister1.asp?IID=11102009PGD1362

For problems or questions regarding online registration, contact us at: 800-232-4422

Speaker
: Damian Peters, Pharm. D. Certified Consultant Pharmacist
Program Goal

To obtain continuing education contact hours for this event, be sure to obtain the "Instruction Page" from the program planner. This Instruction Page will outline the process for completing online fulfillment and printing of your CE Statement of Credit.
: The goal of this program is to provide information to assist in the prevention, identification, and treatment of diabetes complications.There are no fees for this program.

The American Association of Diabetes Educators is accredited by the Accreditation Council for

Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.50

contact hours (0.15 CEU’s) of continuing education credit.

ACPE Universal Program Number:
069-999-08-199-L01-P
Program Release Date:
9/11/2008 Program Expiration Date: 9/11/2010
The approval of this educational offering by AADE does not imply endorsement of specific therapies, treatments, or products discussed in the presentation.

This program is supported by an educational grant from Novo Nordisk Inc.

Pat Resto, President

757-867-7343 or 757-869-2691

NOVO-NORDISK, INC